Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Why Some Consider the New Crisis to be European Banks
31:54 - European lenders have so much access to funding that worries about the failure of a large global bank haven’t kept Goldman Sachs Group Inc. from dealing with them, Chief Executive Officer Lloyd Blankfein said. “By and large, we haven’t been that worried about the big global banks, but I won’t write a blank check on that,” Blankfein said Tuesday at an investor conference in Miami. Alvine Capital Management Investment Committee Chairman Stephen Isaacs discusses the outlook of the European banking sector with Bloomberg’s Manus Cranny and Anna Edwards on “Countdown.”
  • How Bleak Does the Future Look for Miners?
  • UniCredit’s Ghizzoni Survives Calls for Management Shift
  • Central Bank Policies: Do We Need New Tools?